Maxine Gauntlett

I joined the Oncology Clinical Trials Office (OCTO) as a Clinical Trial Administrator in January 2019. Prior to this I was a Clinical Research Practitioner at Berkshire Cancer Centre in Reading as well as  a registered hospital Pharmacy Technician.

I am currently working on 3 different oncology studies;

NEOPANC-01 - A  phase 0, pre-operative, window-of-opportunity study to assess gene expression in patients with resectable pancreatic cancer 

CEDAR - A Phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer 

OxPLoreD - Oxford Pre-cancerous Lymphoproliferative Disorders: Analysis and Interception study